Boston Trust Walden Corp lowered its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 69.6% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 743 shares of the semiconductor company’s stock after selling 1,704 shares during the quarter. Boston Trust Walden Corp’s holdings in Synopsys were worth $349,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also made changes to their positions in SNPS. Vanguard Group Inc. increased its holdings in Synopsys by 20.7% in the third quarter. Vanguard Group Inc. now owns 18,181,185 shares of the semiconductor company’s stock valued at $8,970,415,000 after purchasing an additional 3,120,401 shares during the last quarter. Victory Capital Management Inc. boosted its holdings in Synopsys by 238.8% during the third quarter. Victory Capital Management Inc. now owns 2,824,349 shares of the semiconductor company’s stock worth $1,393,506,000 after buying an additional 1,990,608 shares during the last quarter. Coatue Management LLC acquired a new position in shares of Synopsys during the 3rd quarter worth about $892,605,000. Capital Research Global Investors increased its stake in shares of Synopsys by 226.6% in the 3rd quarter. Capital Research Global Investors now owns 2,524,512 shares of the semiconductor company’s stock valued at $1,245,533,000 after acquiring an additional 1,751,432 shares during the last quarter. Finally, State Street Corp increased its stake in shares of Synopsys by 20.6% in the 3rd quarter. State Street Corp now owns 8,760,358 shares of the semiconductor company’s stock valued at $4,322,273,000 after acquiring an additional 1,493,912 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors.
Synopsys Trading Down 4.3%
NASDAQ:SNPS opened at $456.85 on Friday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.36 and a quick ratio of 1.26. The business’s 50-day simple moving average is $424.75 and its 200-day simple moving average is $445.17. Synopsys, Inc. has a fifty-two week low of $376.18 and a fifty-two week high of $651.73. The stock has a market capitalization of $87.51 billion, a PE ratio of 70.94, a price-to-earnings-growth ratio of 3.90 and a beta of 1.15.
Synopsys (NASDAQ:SNPS – Get Free Report) last posted its earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.56 by $0.21. The business had revenue of $2.41 billion during the quarter, compared to analysts’ expectations of $2.39 billion. Synopsys had a return on equity of 6.83% and a net margin of 13.76%.Synopsys’s revenue for the quarter was up 65.6% compared to the same quarter last year. During the same period in the prior year, the business earned $3.03 EPS. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. Sell-side analysts expect that Synopsys, Inc. will post 10.3 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of analysts recently weighed in on SNPS shares. The Goldman Sachs Group set a $600.00 price target on shares of Synopsys and gave the company a “buy” rating in a research report on Wednesday, February 25th. Weiss Ratings restated a “hold (c)” rating on shares of Synopsys in a report on Thursday, January 22nd. HSBC lowered shares of Synopsys from a “buy” rating to a “hold” rating and set a $455.00 target price on the stock. in a report on Friday, February 20th. Morgan Stanley reissued an “equal weight” rating and set a $480.00 price target (down from $550.00) on shares of Synopsys in a research report on Wednesday, February 25th. Finally, Needham & Company LLC reissued a “buy” rating on shares of Synopsys in a report on Thursday, February 26th. Eight research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Synopsys presently has an average rating of “Hold” and an average target price of $531.00.
Check Out Our Latest Stock Report on SNPS
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Synopsys and related companies with MarketBeat.com’s FREE daily email newsletter.
